The Alarming Rise of Million-Dollar Health Claims
The United States healthcare landscape is facing a significant and troubling trend: million-dollar health claims are surging at an unprecedented rate. According to the latest High-Cost Claims and Injectable Drug Trends report from Sun Life U.S., there has been a staggering 46% spike in claims exceeding one million dollars. Based on an analysis of more than 70,000 high-dollar claims from self-funded employers, the report shines a light on the complex web of medical, pharmaceutical, and demographic factors pushing healthcare costs to historic highs. Understanding these drivers is no longer optional for HR professionals, benefits administrators, and business leaders — it is an urgent strategic necessity.
The Three Biggest Culprits Behind Skyrocketing Claims
The Sun Life report identifies three primary contributors to the surge in high-cost claims. Each of these factors is deeply interconnected with broader trends in medicine, population health, and pharmaceutical innovation.
1. Secondary (Comorbid) Conditions
Comorbidities — the presence of one or more additional conditions alongside a primary diagnosis — have long been a major driver of high-cost healthcare claims, but their impact is growing. When a patient presents with multiple conditions simultaneously, treatment plans become significantly more complicated. Secondary diagnoses can exacerbate the primary condition, delay recovery, and require layered interventions that multiply costs rapidly.
The report identifies particularly strong connections between cancer, cardiovascular disease, chronic kidney disease, and orthopedic or musculoskeletal (MSK) conditions. These conditions share common risk factors including age, obesity, diabetes, and systemic inflammation. As the American workforce ages and rates of obesity and metabolic disease continue to climb, the prevalence of complex comorbid presentations is expected to grow — and so will their associated costs.
2. Long Inpatient Hospitalizations
Extended hospital stays remain one of the most direct pathways to catastrophic claims. Patients with severe primary diagnoses compounded by secondary conditions are far more likely to require prolonged inpatient care, intensive monitoring, and high levels of clinical resource utilization. Long hospitalizations not only drive up direct costs such as room, board, and nursing care, but they also increase exposure to hospital-acquired complications, further extending stays and inflating total claim values.
For self-funded employers — who bear the direct financial risk of their employees' healthcare expenses — even a single prolonged hospitalization can have a meaningful impact on annual plan costs. Proactive case management and care coordination programs have become essential tools for employers seeking to reduce unnecessary hospital days and support appropriate transitions to lower-acuity care settings.
3. Injectable and Specialty Drugs
Specialty injectable medications represent one of the fastest-growing cost categories in employer-sponsored health plans. These drugs, often used to treat complex conditions such as cancer, autoimmune disorders, and rare genetic diseases, can carry per-dose price tags that dwarf traditional pharmaceuticals. The emergence of gene therapies — some with one-time treatment costs reaching several million dollars — has introduced an entirely new tier of financial exposure for plan sponsors.
The report specifically highlights injectable drugs as a major driver of multimillion-dollar claims. As more specialty biologics and gene therapies receive FDA approval and enter the market, the frequency and magnitude of these claims is expected to increase. Employers and insurers alike are scrambling to develop formulary strategies, carve-out arrangements, and stop-loss protections to manage this evolving risk.
Conditions Most Commonly Associated With Claims Over $3 Million
While any severe illness can generate extraordinary costs under the right circumstances, certain diagnoses appear most frequently in claims exceeding three million dollars. The Sun Life report highlights three standout categories.
Orthopedic and Musculoskeletal Conditions
Perhaps the most surprising finding in the report is the emergence of orthopedic and musculoskeletal conditions as a leading driver of multimillion-dollar claims. Historically, these conditions were associated with moderate-to-high costs, but they had not typically reached the same catastrophic levels as cancer or premature birth. Their recent ascension to the top tier reflects both an increase in severity — potentially tied to higher rates of obesity and sedentary lifestyles — and the development of new, expensive therapies and surgical techniques. Notably, orthopedic and MSK conditions are also among the most common diagnoses for short-term disability claims, suggesting a compounding effect on total employer costs.
Cancer
Cancer has been a perennial top driver of high-cost claims, and that status shows no sign of changing. Advances in oncology have dramatically improved survival rates for many cancers, but they have also introduced extraordinarily expensive treatment regimens involving immunotherapy, targeted biologics, and precision medicine. The intersection of cancer with comorbid cardiovascular or kidney disease further escalates costs and complicates clinical management.
Premature Birth
Premature births and the neonatal intensive care unit (NICU) stays they require have consistently ranked among the most expensive claims in employer health plans. Extremely premature infants may spend weeks or months in intensive care, requiring specialized interventions, surgeries, and follow-up services that easily generate seven-figure costs. Despite advances in neonatal medicine, premature birth remains an unpredictable and financially devastating event for health plan sponsors.
What Can Employers and HR Leaders Do?
The 46% spike in million-dollar claims is not simply a statistic — it is a call to action for organizations that sponsor employee health benefits. Proactive strategies can meaningfully reduce both the frequency and severity of high-cost claims.
- Invest in preventive care and chronic disease management programs to address the root risk factors — obesity, diabetes, hypertension — that feed into comorbid, high-cost conditions before they escalate.
- Implement robust case management for employees with complex diagnoses to ensure coordinated, evidence-based care that reduces unnecessary hospitalizations and duplicate services.
- Review specialty drug management strategies, including working with pharmacy benefit managers (PBMs) to implement formulary controls, step therapy protocols, and biosimilar adoption policies.
- Evaluate stop-loss coverage carefully, ensuring that specific and aggregate attachment points appropriately reflect the evolving risk environment, particularly given the growing threat of gene therapy costs.
- Leverage data analytics to identify at-risk employees early, enabling targeted interventions before conditions worsen and claims escalate.
The Road Ahead: A Systemic Challenge Requiring Systemic Solutions
The 46% rise in million-dollar health claims is the product of multiple converging forces: an aging and increasingly comorbid workforce, rapid pharmaceutical innovation outpacing affordability frameworks, and a healthcare delivery system still struggling to coordinate care effectively for complex patients. No single intervention will reverse this trend. What is required is a comprehensive, data-driven approach that aligns clinical, financial, and human resources strategies around the shared goal of sustainable, high-quality healthcare.
For employers, benefits consultants, and HR leaders, the Sun Life report serves as both a diagnostic tool and a strategic roadmap. The data is clear — the question now is whether organizations will act on it with the urgency it demands.